Health and Disease After Assisted Reproductive Technology
Fertility & Reproduction · 2019
DOI: 10.1142/s2661318219300095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fertility & Reproduction, 2019. Verfasst von Cathy Allen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Long-term health outcomes after ART have largely focused on offspring health and perinatal parameters. Longer-term health outcomes in female patients remain difficult to fully assess. Hypothetical concerns about the effects of endocrine manipulation on hormone-sensitive conditions, e.g. breast disease, are confounded by variable factors in patients and treatments. Obstetric and perinatal factors endow an additional layer of complexity to the overall analysis and more research is required to appreciate all aspects of ART. Notwithstanding the knowledge gap, clinicians must endeavour to individualise management plans, taking into account the pros and cons of ART in the context of immediate, maternity-related and long-term health risks for their patients. This review of recent literature examines current ART practice in terms of female health and disease as we strive for best practice in an ever-changing clinical and demographic fertility landscape.
Zitieren
APA
Allen, C. (2019). Health and Disease After Assisted Reproductive Technology. Fertility & Reproduction. https://doi.org/10.1142/s2661318219300095
Vancouver
Allen C. Health and Disease After Assisted Reproductive Technology. Fertility & Reproduction. 2019. doi:10.1142/s2661318219300095
BibTeX
@article{Allen2019,
author = {Allen, Cathy},
title = {Health and Disease After Assisted Reproductive Technology},
journal = {Fertility & Reproduction},
year = {2019},
doi = {10.1142/s2661318219300095}
}
EUVIMED